Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study

NCT05263778 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
NSTEMI
STEMI

Interventions

DRUG: Bempedoic Acid / Ezetimibe Oral Tablet
DRUG: Placebo

Sponsor

Kaiser Permanente

Collaborators

[object Object]